Week of September 17 - 23, 2017
Copanlisib (Aliqopa ™) is a kinase inhibitor used to treat patients with relapsed follicular lymphoma.
Bevacizumab-awwb (Mvasi) is a biosimilar monoclonal antibody used in the treatment of some cancers.
A free nursing continuing education module.
Gemtuzumab Ozogamicin (Mylotarg ™) is a chemotherapy drug used in the treatment of CD33-positive acute myeloid leukemia.
Inotuzumab Ozogamicin (Bespona ™) is a chemotherapy used in the treatment of relapsed of refractory B-cell lymphoblastic leukemia.
A medication used in the treatment of relapsed or refractory acute myeloid leukemia.
a combination of two medications, used in the treatment of AML.
Accepting a feeding tube can be hard, but it doesn't mean you have to stop living.
Bob shares his experience with pancreatic cancer and what it has taught him.
Joe shares his story about his experience with head and neck cancer.
Laura's story of living after treatment for osteosarcoma with late effects of her cancer treatments.
A kinase inhibitor that works by blocking EGFR and HER kinases.
A monoclonal antibody used in the treatment of lymphoma.
Marlys shares her story of survival as a caregiver to her husband Gary who lived for 10 years with advanced prostate cancer.
Doug shares his story of survival after being diagnosed with Stage 4 non-Hodgkin's lymphoma 23 years ago.
Updated for 2017! Our webucation program guides you through diagnosis, treatment and coping with lung cancer.
A review of the surgical procedures used in the diagnosis and treatment of soft tissue sarcomas.
Information about feeding tubes, which are used to supply nutrition when an individual is unable to eat or absorb nutrients through the gastrointestinal (GI) tract.
Midostaurin (Rydapt ®) is a kinase inhibitor used in the treatment of AML that is FLT3 mutation positive and mast cell leukemia.
Basic information about Multiple Myeloma, its diagnosis and treatment.
Take our short survey and help us plan future projects!
OncoLink coverage of sessions at the 56th Annual Conference of the Particle Therapy Co-operative Group in Japan.